| 0 |
Echinocandin Antifungal [EPC] |
25 |
0.0030 |
| 1 |
Cytomegalovirus DNA Terminase Complex Inhibitor [EPC] |
5 |
0.0015 |
| 2 |
Lipid-based Polyene Antifungal [EPC] |
12 |
0.0009 |
| 3 |
Antimetabolite Immunosuppressant [EPC] |
19 |
0.0009 |
| 4 |
Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] |
19 |
0.0009 |
| 5 |
Carnitine Analog [EPC] |
2 |
0.0005 |
| 6 |
SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC] |
7 |
0.0005 |
| 7 |
CD30-directed Immunoconjugate [EPC] |
4 |
0.0004 |
| 8 |
Monobactam Antibacterial [EPC] |
1 |
0.0004 |
| 9 |
Polyene Antifungal [EPC] |
13 |
0.0003 |
| 10 |
Azole Antifungal [EPC] |
49 |
0.0003 |
| 11 |
Asparagine-specific Enzyme [EPC] |
4 |
0.0003 |
| 12 |
Tetracycline-class Antibacterial [EPC] |
2 |
0.0003 |
| 13 |
Penem Antibacterial [EPC] |
8 |
0.0002 |
| 14 |
alpha-1 Adrenergic Agonist [EPC] |
1 |
0.0002 |
| 15 |
Oxazolidinone Antibacterial [EPC] |
5 |
0.0002 |
| 16 |
Glycopeptide Antibacterial [EPC] |
10 |
0.0002 |
| 17 |
Human Immunoglobulin G [EPC] |
3 |
0.0001 |
| 18 |
Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] |
3 |
0.0001 |
| 19 |
Alkylating Drug [EPC] |
30 |
0.0001 |
| 20 |
Calcineurin Inhibitor Immunosuppressant [EPC] |
16 |
0.0001 |
| 21 |
Nucleoside Analog Antiviral [EPC] |
10 |
0.0001 |
| 22 |
Aminoglycoside Antibacterial [EPC] |
5 |
0.0001 |
| 23 |
Nitroimidazole Antimicrobial [EPC] |
7 |
0.0001 |
| 24 |
Janus Kinase Inhibitor [EPC] |
16 |
0.0001 |
| 25 |
Protease Inhibitor [EPC] |
4 |
0.0001 |
| 26 |
Complement Inhibitor [EPC] |
5 |
0.0001 |
| 27 |
Corticosteroid [EPC] |
111 |
0.0001 |
| 28 |
Nucleoside Metabolic Inhibitor [EPC] |
22 |
0.0001 |
| 29 |
Interleukin-6 Receptor Antagonist [EPC] |
11 |
0.0001 |
| 30 |
Purine Antimetabolite [EPC] |
7 |
0.0001 |
| 31 |
Fluoroquinolone Antibacterial [EPC] |
9 |
0.0001 |
| 32 |
Cytochrome P450 3A Inhibitor [EPC] |
4 |
0.0001 |
| 33 |
CD20-directed Cytolytic Antibody [EPC] |
18 |
0.0001 |
| 34 |
Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] |
6 |
0.0001 |
| 35 |
Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] |
6 |
0.0001 |
| 36 |
CD52-directed Cytolytic Antibody [EPC] |
1 |
0.0001 |
| 37 |
Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] |
6 |
0.0001 |
| 38 |
Tetracycline-class Drug [EPC] |
3 |
0.0000 |
| 39 |
Proteasome Inhibitor [EPC] |
4 |
0.0000 |
| 40 |
Iron Chelator [EPC] |
1 |
0.0000 |
| 41 |
Dihydrofolate Reductase Inhibitor Antibacterial [EPC] |
3 |
0.0000 |
| 42 |
Kinase Inhibitor [EPC] |
17 |
0.0000 |
| 43 |
Catecholamine [EPC] |
2 |
0.0000 |
| 44 |
Leukocyte Growth Factor [EPC] |
3 |
0.0000 |
| 45 |
Aminosalicylate [EPC] |
2 |
0.0000 |
| 46 |
Topoisomerase Inhibitor [EPC] |
1 |
0.0000 |
| 47 |
Folate Analog Metabolic Inhibitor [EPC] |
4 |
0.0000 |
| 48 |
Sulfonylurea [EPC] |
1 |
0.0000 |
| 49 |
Thalidomide Analog [EPC] |
4 |
0.0000 |
| 50 |
Atypical Antipsychotic [EPC] |
2 |
0.0000 |